Lara Longpre, Chief Development Officer at Mirum Pharmaceuticals, Inc. (MIRM), sold 1,004 shares at $25.65 ($26K) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Open-market sale of $26k MIRM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-02-05 | $22K | — | Filing → |
| MIRM | SELL | 2024-01-09 | $29K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $19K | — | Filing → |